[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2)

Request For Quotation
[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2) Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2) Basic information
Product Name:[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2)
Synonyms:[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2)
CAS:197366-24-8
MF:C58H63N24NaO22S6
MW:1663.64
EINECS:
Product Categories:
Mol File:197366-24-8.mol
[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2) Structure
[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2) Chemical Properties
Safety Information
MSDS Information
[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2) Usage And Synthesis
UsesRFI-641 is a selective inhibitor of the respiratory syncytial virus (RSV), with an IC50 of 50 nM. RFI-641 inhibit binding and fusion of enveloped virus via interaction with the viral fusion protein[1].
References[1] Nikitenko AA, et, al. The discovery of RFI-641 as a potent and selective inhibitor of the respiratory syncytial virus. Bioorg Med Chem Lett. 2001 Apr 23;11(8):1041-4. DOI:10.1016/s0960-894x(01)00150-0
[2] Razinkov V, et, al. RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein. Chem Biol. 2001 Jul;8(7):645-59. DOI:10.1016/s1074-5521(01)00042-4
[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2) Preparation Products And Raw materials
Tag:[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2)(197366-24-8) Related Product Information
[1,1'-Biphenyl]-2,2'-disulfonic acid, 4,4'-bis[[4,6-bis[[3-[[bis(2-amino-2-oxoethyl)amino]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2) FUSION GLYCOPROTEIN F0/F protein, HRSV (AFX60213, SF9, HIS) GLYCOPROTEIN/G protein, HRSV (258A.A, HEK293, HIS) Motavizumab Presatovir Ribavirin